We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generic drug developers that use patches, inhalers, drops or similar means to deliver meds should create separate clinical trials to test for potential side effects like skin irritation and, in the case of patches, adhesion quality, the FDA says. Read More
Consumers look to generic drugs for their cheaper price tags. But a new study finds sudden price spikes for generics are becoming more common. Read More
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is seeking industry feedback on a potential no-deal Brexit scenario in which the agency would function as a medicine and medical device regulator on its own. Read More
Westminster Pharmaceuticals and CVS committed fraud in knowingly selling adulterated thyroid drugs, according to a class-action federal lawsuit. Read More
“Cutting list prices and rolling back proposed increases in particular are an unprecedented recognition of the fundamental changes going on in drug markets,” said Dan Best, senior advisor to the HHS Secretary for drug pricing reform. Read More
“Bringing transparency to drug pricing and educating the public about the cost of their prescriptions is common sense,” said Sen. Chuck Grassley (R-Iowa). Read More